Results 151 to 160 of about 1,113 (191)
Ocular Drug Delivery: Emerging Approaches and Advances. [PDF]
PharmaceuticsGade S +8 more
europepmc +1 more source
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants. [PDF]
Ophthalmol TherHolekamp NM +5 more
europepmc +1 more source
A Novel Technique for Repositioning of a Migrated ILUVIEN® (Fluocinolone Acetonide) Implant into the Anterior Chamber [PDF]
Ophthalmology and Therapy, 2015 Fluocinolone acetonide (FAc) intravitreal implant (ILUVIEN(®); Alimera Sciences Limited, Aldershot, UK) has been approved in the UK for the treatment of chronic diabetic macula edema, insufficiently responsive to available therapies. It is inserted into the vitreous cavity through a 25-gauge needle. Migration of the implant to the anterior chamber (AC)
Christiana Dinah
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
European Journal of Ophthalmology, 2022
Purpose Macular edema can be observed in 20% of patients with retinitis pigmentosa (RP) and is often responsible of central vision impairment. Intraocular administration of corticosteroids (either triamcinolone or dexamethasone implant) has been found to be effective in that indication.
Emilie Jomaa +2 more
openaire +3 more sources
Purpose Macular edema can be observed in 20% of patients with retinitis pigmentosa (RP) and is often responsible of central vision impairment. Intraocular administration of corticosteroids (either triamcinolone or dexamethasone implant) has been found to be effective in that indication.
Emilie Jomaa +2 more
openaire +3 more sources
OBSERVATION: FLUOCINOLONE ACETONIDE (ILUVIEN) IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER
RETINAL Cases & Brief Reports, 2017Purpose: To describe the anterior chamber migration of a fluocinolone acetonide (Iluvien) implant in the context of previous vitrectomy and complicated cataract surgery. Methods: Retrospective observational case series.
Papastavrou, Vasileios T +4 more
openaire +3 more sources
Management of Steroid Induced Glaucoma following the Iluvien (Fluocinolone) Implant: A UK Survey [PDF]
Journal of Ophthalmic Research and Ocular Care, 2020 Vithlani Sejal, Zambarakji Hadi
exaly +2 more sources
Iluvien™: a new sustained delivery technology for posterior eye disease
Expert Opinion on Drug Delivery, 2008Iluvien (fluocinolone acetonide intravitreal insert, Alimera Sciences, Inc.), a novel injectable intravitreal insert, is being studied to deliver a very low dose of a corticosteroid to the retina for up to 3 years as a treatment for diabetic macular edema.
Frances E, Kane +3 more
openaire +2 more sources
Fluocinolone Acetonide Intravitreal Implant (Iluvien®)
Drugs, 2013Fluocinolone acetonide intravitreal implant (Iluvien®) is an injectable, non-erodible, corticosteroid implant that is approved in several European countries for the treatment of chronic diabetic macular oedema (DMO). In analyses of two multinational trials in patients with DMO previously treated with macular laser photocoagulation, fluocinolone ...
openaire +2 more sources